Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction

Mark Emberton (1)

1 UCLH/UCL Comprehensive Biomedical Centre

Background/aims: Practice guidelines acknowledge the importance of patient preferences in determining the appropriate treatment of benign prostatic hyperplasia (BPH). Recent literature suggests that patient and physician perspectives and satisfaction with BPH treatment management may differ; this may have an impact on clinical outcomes and patient compliance. This review evaluates patients' and physicians' preferred treatment options for managing BPH and patient satisfaction with therapy. Methods: A Medline-based systematic review using the terms ‘Benign prostatic hyperplasia' + ‘Patient preference/perception/satisfaction' or ‘Physician/urologist preference/perception' was performed. Results: Patients prefer therapies affecting long-term disease progression over those that provide short-term symptom improvement, which contrasts with the beliefs of their physicians. The prescribing behaviour of urologists and primary care physicians can be very varied. Studies of patient satisfaction with specific treatments generally show a high level of overall satisfaction, but cross-study comparisons are limited due to heterogeneity in study design. Conclusions: The evidence to date suggests that patients' views and beliefs and those of their physician may not always be in agreement. Improved physician–patient communication will help determine the best treatment option for patients with BPH and may ensure greater compliance and treatment success.

Mots clés: Medicine

Mark Emberton. Medical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfaction. International Journal of Clinical Practice, 2010, 64 (10), pp.1425. ⟨10.1111/j.1742-1241.2010.02463.x⟩. ⟨hal-00552667⟩